Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1997 Apr;73(858):215–221. doi: 10.1136/pgmj.73.858.215

Haemopoietic growth factors.

N J Ketley 1, A C Newland 1
PMCID: PMC2431295  PMID: 9156123

Abstract

Haemopoietic growth factors are involved in the production of the various blood cells from progenitors in the bone marrow, making them useful in a range of clinical situations. The genes for several of them have been cloned and their production engineered by recombinant technology, making them widely available. Myeloid growth factors are used to support patients in the aftermath of chemotherapy and bone marrow transplantation and have potential application in the treatment of infectious diseases. Erythropoietin is widely used for patients with anaemia due to failure of marrow production, having established its effectiveness in chronic renal failure. Thrombopoietin has recently been described and may provide a means to alleviate thrombocytopenia. Current indications and areas of recent reappraisal are addressed in this review.

Full text

PDF
216

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin G. C., Gasson J. C., Quan S. G., Fleischmann J., Weisbart R., Oette D., Mitsuyasu R. T., Golde D. W. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2763–2766. doi: 10.1073/pnas.85.8.2763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Biesma D. H., Marx J. J., Kraaijenhagen R. J., Franke W., Messinger D., van de Wiel A. Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin. Lancet. 1994 Aug 6;344(8919):367–370. doi: 10.1016/s0140-6736(94)91401-x. [DOI] [PubMed] [Google Scholar]
  3. Blaese R. M. Development of gene therapy for immunodeficiency: adenosine deaminase deficiency. Pediatr Res. 1993 Jan;33(1 Suppl):S49–S55. doi: 10.1203/00006450-199305001-00278. [DOI] [PubMed] [Google Scholar]
  4. Bonilla M. A., Gillio A. P., Ruggeiro M., Kernan N. A., Brochstein J. A., Abboud M., Fumagalli L., Vincent M., Gabrilove J. L., Welte K. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989 Jun 15;320(24):1574–1580. doi: 10.1056/NEJM198906153202402. [DOI] [PubMed] [Google Scholar]
  5. Brenner M. K., Rill D. R., Moen R. C., Krance R. A., Mirro J., Jr, Anderson W. F., Ihle J. N. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet. 1993 Jan 9;341(8837):85–86. doi: 10.1016/0140-6736(93)92560-g. [DOI] [PubMed] [Google Scholar]
  6. Brenner M. K. The contribution of marker gene studies to hemopoietic stem cell therapies. Stem Cells. 1995 Sep;13(5):453–461. doi: 10.1002/stem.5530130502. [DOI] [PubMed] [Google Scholar]
  7. Brugger W., Frommhold H., Pressler K., Mertelsmann R., Kanz L. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer. Semin Oncol. 1995 Feb;22(1 Suppl 2):3–8. [PubMed] [Google Scholar]
  8. Brugger W., Heimfeld S., Berenson R. J., Mertelsmann R., Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med. 1995 Aug 3;333(5):283–287. doi: 10.1056/NEJM199508033330503. [DOI] [PubMed] [Google Scholar]
  9. Crawford J., Ozer H., Stoller R., Johnson D., Lyman G., Tabbara I., Kris M., Grous J., Picozzi V., Rausch G. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med. 1991 Jul 18;325(3):164–170. doi: 10.1056/NEJM199107183250305. [DOI] [PubMed] [Google Scholar]
  10. Dong F., Brynes R. K., Tidow N., Welte K., Löwenberg B., Touw I. P. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med. 1995 Aug 24;333(8):487–493. doi: 10.1056/NEJM199508243330804. [DOI] [PubMed] [Google Scholar]
  11. Dührsen U., Hossfeld D. K. Hematopoietic growth factors and the treatment of tumor-associated anemias. Ann Hematol. 1994 Nov;69(5):213–221. doi: 10.1007/BF01700275. [DOI] [PubMed] [Google Scholar]
  12. Eschbach J. W., Abdulhadi M. H., Browne J. K., Delano B. G., Downing M. R., Egrie J. C., Evans R. W., Friedman E. A., Graber S. E., Haley N. R. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med. 1989 Dec 15;111(12):992–1000. doi: 10.7326/0003-4819-111-12-992. [DOI] [PubMed] [Google Scholar]
  13. Estey E. H. Use of colony-stimulating factors in the treatment of acute myeloid leukemia. Blood. 1994 Apr 15;83(8):2015–2019. [PubMed] [Google Scholar]
  14. Estey E., Thall P. F., Kantarjian H., O'Brien S., Koller C. A., Beran M., Gutterman J., Deisseroth A., Keating M. Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF. Blood. 1992 May 1;79(9):2246–2255. [PubMed] [Google Scholar]
  15. Fischl M., Galpin J. E., Levine J. D., Groopman J. E., Henry D. H., Kennedy P., Miles S., Robbins W., Starrett B., Zalusky R. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med. 1990 May 24;322(21):1488–1493. doi: 10.1056/NEJM199005243222103. [DOI] [PubMed] [Google Scholar]
  16. Forni G., Parmiani G., Guarini A., Foà R. Gene transfer in tumor therapy. Ann Oncol. 1994 Nov;5(9):789–794. doi: 10.1093/oxfordjournals.annonc.a059006. [DOI] [PubMed] [Google Scholar]
  17. Gerhartz H. H., Engelhard M., Meusers P., Brittinger G., Wilmanns W., Schlimok G., Mueller P., Huhn D., Musch R., Siegert W. Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas. Blood. 1993 Oct 15;82(8):2329–2339. [PubMed] [Google Scholar]
  18. Gianni A. M. Where do we stand with respect to the use of peripheral blood progenitor cells? Ann Oncol. 1994 Nov;5(9):781–784. doi: 10.1093/oxfordjournals.annonc.a059003. [DOI] [PubMed] [Google Scholar]
  19. Giralt S., Escudier S., Kantarjian H., Deisseroth A., Freireich E. J., Andersson B. S., O'Brien S., Andreeff M., Fisher H., Cork A. Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. N Engl J Med. 1993 Sep 9;329(11):757–761. doi: 10.1056/NEJM199309093291103. [DOI] [PubMed] [Google Scholar]
  20. Gisselbrecht C., Prentice H. G., Bacigalupo A., Biron P., Milpied N., Rubie H., Cunningham D., Legros M., Pico J. L., Linch D. C. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation. Lancet. 1994 Mar 19;343(8899):696–700. doi: 10.1016/s0140-6736(94)91579-2. [DOI] [PubMed] [Google Scholar]
  21. Goodnough L. T. Clinical application of recombinant erythropoietin in the perioperative period. Hematol Oncol Clin North Am. 1994 Oct;8(5):1011–1020. [PubMed] [Google Scholar]
  22. Gordon M. Y., Blackett N. M. Routes to repopulation--a unification of the stochastic model and separation of stem-cell subpopulations. Leukemia. 1994 Jun;8(6):1068–1073. [PubMed] [Google Scholar]
  23. Hammond W. P., 4th, Price T. H., Souza L. M., Dale D. C. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med. 1989 May 18;320(20):1306–1311. doi: 10.1056/NEJM198905183202003. [DOI] [PubMed] [Google Scholar]
  24. Holyoake T. L., Franklin I. M. Bone marrow transplants from peripheral blood. BMJ. 1994 Jul 2;309(6946):4–5. doi: 10.1136/bmj.309.6946.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jyung R. W., Wu L., Pierce G. F., Mustoe T. A. Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing. Surgery. 1994 Mar;115(3):325–334. [PubMed] [Google Scholar]
  26. Kaplan G., Walsh G., Guido L. S., Meyn P., Burkhardt R. A., Abalos R. M., Barker J., Frindt P. A., Fajardo T. T., Celona R. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med. 1992 Jun 1;175(6):1717–1728. doi: 10.1084/jem.175.6.1717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Krall W. J., Challita P. M., Perlmutter L. S., Skelton D. C., Kohn D. B. Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation. Blood. 1994 May 1;83(9):2737–2748. [PubMed] [Google Scholar]
  28. Kuhns D. B., Alvord W. G., Gallin J. I. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis. 1995 Jan;171(1):145–152. doi: 10.1093/infdis/171.1.145. [DOI] [PubMed] [Google Scholar]
  29. Lazarus H. M., Rowe J. M. Clinical use of hematopoietic growth factors in allogeneic bone marrow transplantation. Blood Rev. 1994 Sep;8(3):169–178. doi: 10.1016/0268-960x(94)90078-v. [DOI] [PubMed] [Google Scholar]
  30. Marsh J. C., Socie G., Schrezenmeier H., Tichelli A., Gluckman E., Ljungman P., McCann S. R., Raghavachar A., Marin P., Hows J. M. Haemopoietic growth factors in aplastic anaemia: a cautionary note. European Bone Marrow Transplant Working Party for Severe Aplastic Anaemia. Lancet. 1994 Jul 16;344(8916):172–173. doi: 10.1016/s0140-6736(94)92763-4. [DOI] [PubMed] [Google Scholar]
  31. Metcalf D. Blood. Thrombopoietin--at last. Nature. 1994 Jun 16;369(6481):519–520. doi: 10.1038/369519a0. [DOI] [PubMed] [Google Scholar]
  32. Pincus T., Olsen N. J., Russell I. J., Wolfe F., Harris E. R., Schnitzer T. J., Boccagno J. A., Krantz S. B. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med. 1990 Aug;89(2):161–168. doi: 10.1016/0002-9343(90)90294-n. [DOI] [PubMed] [Google Scholar]
  33. Russell N. H. Autocrine growth factors and leukaemic haemopoiesis. Blood Rev. 1992 Sep;6(3):149–156. doi: 10.1016/0268-960x(92)90026-m. [DOI] [PubMed] [Google Scholar]
  34. Schmitz N., Linch D. C., Dreger P., Goldstone A. H., Boogaerts M. A., Ferrant A., Demuynck H. M., Link H., Zander A., Barge A. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet. 1996 Feb 10;347(8998):353–357. doi: 10.1016/s0140-6736(96)90536-x. [DOI] [PubMed] [Google Scholar]
  35. Sprikkelman A., de Wolf J. T., Vellenga E. The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases. Leukemia. 1994 Dec;8(12):2031–2036. [PubMed] [Google Scholar]
  36. Stone R. M., Berg D. T., George S. L., Dodge R. K., Paciucci P. A., Schulman P., Lee E. J., Moore J. O., Powell B. L., Schiffer C. A. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. N Engl J Med. 1995 Jun 22;332(25):1671–1677. doi: 10.1056/NEJM199506223322503. [DOI] [PubMed] [Google Scholar]
  37. Tafuri A., Andreeff M. Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro. Leukemia. 1990 Dec;4(12):826–834. [PubMed] [Google Scholar]
  38. Triozzi P. L. Autologous bone marrow and peripheral blood progenitor transplant for breast cancer. Lancet. 1994 Aug 13;344(8920):418–419. doi: 10.1016/s0140-6736(94)91762-0. [DOI] [PubMed] [Google Scholar]
  39. Vellenga E., Young D. C., Wagner K., Wiper D., Ostapovicz D., Griffin J. D. The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood. 1987 Jun;69(6):1771–1776. [PubMed] [Google Scholar]
  40. Williams M. A., Kouroumoussis I., Syndercombe-Court D., Hendry L., Newland A. C., Kelsey S. M. Administration of recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy regulates the expression and secretion of monocyte tumor necrosis factor (TNF) and TNF receptors p55 and p75. Blood. 1995 Dec 1;86(11):4234–4242. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES